{"id":30,"name":"Andy Kinley","url":"","description":"Andy Kinley, Ph.D. is Vice President of Innovation and Clinical Science at Precision for Medicine. He is a clinical researcher with over 25 years of combined experience leading basic and clinical research in oncology and hematology. \r\nHis early scientific career focused on cancer cell signaling, setting a foundation to complement his clinical research roles in trial design and implementation of effective strategies for oncology clinical trials. \r\n\r\nAndy specializes in immuno-oncology trials (checkpoint inhibitors, T-cell agonists, bispecifics, cytokines, oncolytic viruses, neoantigen cancer vaccines), including autologous and allogeneic adoptive cell therapies (CAR-T, TCR, TIL, NK cells). Today, Andy identifies and implements innovative tools, datasets, and services that can impact clinical trial execution including quality, patient diversity, site identification, and trial timelines.\r\nAndy is a subject matter expert with Precision ADVANCE, a collection of interconnected services and complementary teams uniquely focused on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market.","link":"https:\/\/lifescivoice.com\/author\/andykinley\/","slug":"andykinley","avatar_urls":{"24":"https:\/\/lifescivoice.com\/wp-content\/uploads\/2023\/03\/andy-jpg.webp","48":"https:\/\/lifescivoice.com\/wp-content\/uploads\/2023\/03\/andy-jpg.webp","96":"https:\/\/lifescivoice.com\/wp-content\/uploads\/2023\/03\/andy-jpg.webp"},"meta":[],"_links":{"self":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/users\/30","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifescivoice.com\/wp-json\/wp\/v2\/users"}]}}